AR028960A1 - READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN - Google Patents

READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN

Info

Publication number
AR028960A1
AR028960A1 ARP010102892A AR028960A1 AR 028960 A1 AR028960 A1 AR 028960A1 AR P010102892 A ARP010102892 A AR P010102892A AR 028960 A1 AR028960 A1 AR 028960A1
Authority
AR
Argentina
Prior art keywords
production
inhibitors
reading
replaced
beta protein
Prior art date
Application number
Other languages
Spanish (es)
Inventor
E Richard Olson
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Priority to ARP010102892 priority Critical patent/AR028960A1/en
Publication of AR028960A1 publication Critical patent/AR028960A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se relaciona con nuevas lactamas que tienen la formula (1) con composiciones farmacéuticas y con métodos para el uso de las mismas. Estos nuevos compuestos inhiben el procesamiento de la proteína precursora amiloide y más específicamente, inhiben la produccion del péptido Ab, actuando así para prevenir la formacion de depositos neurologicos de proteína amiloide. Más particularmente, la presente invencion se relaciona con el tratamiento de afecciones neurologicas relacionadas con la produccion de beta-amiloides, tales como la enfermedad de Alzheimer, y el síndrome de Down. Los sustituyentes Q, R3, R3a, R5, R5a, R6, anillo B, N, X, Y y Z están definidos en la memoria descriptiva.The invention relates to new lactams having the formula (1) with pharmaceutical compositions and with methods for their use. These new compounds inhibit the processing of the amyloid precursor protein and more specifically, inhibit the production of the Ab peptide, thus acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological conditions related to the production of beta-amyloids, such as Alzheimer's disease, and Down syndrome. The substituents Q, R3, R3a, R5, R5a, R6, ring B, N, X, Y and Z are defined in the specification.

ARP010102892 2001-06-15 2001-06-15 READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN AR028960A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP010102892 AR028960A1 (en) 2001-06-15 2001-06-15 READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP010102892 AR028960A1 (en) 2001-06-15 2001-06-15 READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN

Publications (1)

Publication Number Publication Date
AR028960A1 true AR028960A1 (en) 2003-05-28

Family

ID=37515632

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102892 AR028960A1 (en) 2001-06-15 2001-06-15 READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN

Country Status (1)

Country Link
AR (1) AR028960A1 (en)

Similar Documents

Publication Publication Date Title
UY28222A1 (en) CYTOKIN INHIBITORS
EA200400162A1 (en) N- (3-AMINO-2-HYDROXYPROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
CR7743A (en) NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF)
EA200300788A1 (en) DERIVATIVES OF SUBSTITUTED ALKYLAMINS AND THEIR APPLICATION
PT1448564E (en) SUBSTITUTED INDOLIZIN TYPE COMPOUND AND METHODS OF USE
IS8175A (en) Piperazine derivatives and methods of their use
EA200200716A1 (en) ARYL CONDENSED AZOPOLYCYCLIC COMPOUNDS
TR200100377T2 (en) Sucinoylamino lactams as Aß Protein production inhibitors.
YU37904A (en) Benzimidazoles useful as protein kinase inhibitors
EA201001532A1 (en) COMPOUNDS OF PHENYL SUBSTITUTED 2-IMINO-3-METHYL-PYRROLOPYRIMIDINONE AS BACE-1 INHIBITORS, COMPOSITIONS AND THEIR APPLICATION
TW200718422A (en) 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
UY28279A1 (en) FENACILO 2 -HIDROXI - 3 - DIAMINOALCANOS
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
PA8593101A1 (en) COMPOSITIONS FOR THE TREATMENT OF ABNORMAL CELL GROWTH
CY1111693T1 (en) ANTIQUE FACTORS
HUP0202248A2 (en) Compounds useful as anti-inflammatory agents
TW200621777A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
AR077478A2 (en) DERIVATIVES OF OXINDOL REPLACED DRUGS THAT UNDERSTAND AND USE THEMSELVES
CA2379445A1 (en) Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production
UY27774A1 (en) METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
ATE538124T1 (en) IMIDAZOCONDENSED TRICYCLIC COMPOUNDS BASED ON THIAZOLOA4,5-BUPYRIDINE AND PHARMACEUTICAL COMPOSITIONS THEREOF
ECSP024244A (en) USE OF (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID (4´-TRIFLUOROMETHYLPHENYL) -AMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
BR0211761A (en) depsipeptides and processes for preparing them
MXPA02001813A (en) Hydroxyalkanoyl aminolactams and related structures as inhibitors of a beta protein production.
AR028960A1 (en) READING REPLACED WITH CYCLIC SUCCINATES AS INHIBITORS OF THE PRODUCTION OF BETA PROTEIN